Comparative study for integrate Chinese and conventional medicine the the treatment of novel coronavirus pneumonia (COVID-19) in Hu'nan province

Status

Active, not recruiting

Phases

Early Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR2000029960

Enrollment

Unknown

Registered

2020-02-17

Start date

2020-02-28

Completion date

Unknown

Last updated

2020-02-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Novel Coronavirus Pneumonia (COVID-19)

Interventions

Control group:Conventional medicine

Experimental group:integrated Chinese and conventional medicine

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: The diagnostic criteria of novel coronavirus infection pneumonia can be observed and agreed by the patients themselves.

Exclusion criteria

Exclusion criteria: pregnant or lactating women

Design outcomes

Primary

Measure	Time frame
TCM syndrome;	—

Countries

China

Contacts

Public ContactCHEN Xinyu

The First Affiliated Hospital of Hu'nan University of traditional Chinese Medicine

chenxinyuchen@163.com+86 13807312410

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026